COMPASS Pathways to participate in Citi, Morgan Stanley and HC Wainwright investor conferences in September Psychedelics Investing
Seelos Therapeutics Announces Appointment of Margaret Dalesandro to the Board of Directors Psychedelics Investing
Hollister Biosciences Inc. Announces Appointment of Two New Board Members; Kevin Harrington, an original "Shark" from the NBC hit TV series "Shark Tank" and Jakob Ripshtein, the former CFO of Diageo North America and President of Aphria Psychedelics Investing
Awakn Life Sciences CEO Anthony Tennyson: Developing and Delivering the Next Generation of Addiction Treatments Video Interview
Hollister Biosciences Inc. Reports Q2 2021 Financial Results including USD $17.6 million revenue, and USD $3.2 million of Adjusted EBITDA Psychedelics Investing
Hollister Biosciences Inc. Announces 30-Acre Arizona Brand Campus with planned 700,000 square feet of cultivation area and an existing 28,500-square-foot processing and manufacturing facility Psychedelics Investing
Awakn Life Sciences Initiates the First Ketamine Treatment Study for Gambling Addiction Led by Professor Celia Morgan Psychedelics Investing
Silo Wellness Announces $3 Million U.S. Sales and Distribution Partnership for Marley One Line of Functional Mushrooms Psychedelics Investing
